Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

The presence of SH2B3 mutations identifies a distinct subtype of myelodysplastic neoplasms

Blood (2025) 146 (Supplement 1): 2070.

https://doi.org/10.1182/blood-2025-2070

Published: 2025

Journal Articles

Refining the prognostic hierarchy of TP53 multihit alterations and isolated deletion of chromosome 5q in myelodysplastic syndromes

Blood (2025) 146 (Supplement 1): 2068.

https://doi.org/10.1182/blood-2025-2068

Published: 2025

Journal Articles

Intermediate and high-risk clonal hematopoiesis in germline predisposition families

Sandra Novoa Jáuregui, Sara Torres-Esquius, Maria Gabarrós Subirà, Pamela Acha, Francisco Beas, Ana Maria Garrido, Marc Bosch-Schips, Claudia Pellin Jou, Adriana Oños, Sílvia Saumell Tutusaus, Ana Perez Gonzalez, Adoracion Blanco, David Valcarcel, Francesc Bosch Albareda, Andres Jerez, Maria Julia Montoro

Blood (2025) 146 (Supplement 1): 2058.

https://doi.org/10.1182/blood-2025-2058

Published: 2025

Journal Articles

Hematologic neoplasms with germline DDX41 variants: Experience from nine spanish centers.

Miguel López-Esteban, Sara Torres-Esquius, Esperanza Tuset, Beatriz Gómez-Horsfield, Susana Vives, Jordi Viñas, Raquel De Paz Arias, Montserrat Arnan, Elena Bechtold, Lucía Pérez-Lamas, Carmen Talarn, Juan Restrepo, Yanira Florido, Ruth Stuckey, Ramon Garcia-Sanz, Ismael Buño, Maria Julia Montoro, Andres Jerez, Carolina Martinez-Laperche

Blood (2025) 146 (Supplement 1): 6744.

https://doi.org/10.1182/blood-2025-6744

Published: 2025

Journal Articles

AI-based characterization of terminal erythroid differentiation as a prognostic biomarker in myelodysplastic syndromes

David Bermejo-Peláez, Marta Hidalgo Soto, Adriana Oños, Nuria Diez, David Brau, Ana Mendoza Martínez, Miguel Gómez Álvarez, Sandra Rodríguez, Sílvia Saumell Tutusaus, Mayda Navarrete, Sara Garrido Paniagua, Celina Benavente, Joaquin Martinez Lopez, Miguel Luengo-Oroz, Maria Julia Montoro

Blood (2025) 146 (Supplement 1): 2879.

https://doi.org/10.1182/blood-2025-2879

Published: 2025

Journal Articles

Performance and clinical utility of germline genetic testing criteria for predisposition to myeloid neoplasms in adults

Sara Torres-Esquius, Maria Gabarros-Subira, Maria Eugenia Rivero, Guillermo Ramil López, Lucia García Mañó, Felix Lopez, Concepción Fernandez, Francesca Guijarro, Marina Díaz-Beyá, Marta Pratcorona Canela, Pamela Acha, Sandra Novoa Jáuregui, Esperanza Tuset, Laura Palomo, David Valcarcel, Francesc Bosch Albareda, Andres Jerez, Maria Julia Montoro

Blood (2025) 146 (Supplement 1): 4998.

https://doi.org/10.1182/blood-2025-4998

Published: 2025

Journal Articles

Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy

Sara Torres-Esquius, Maria Gabarros-Subira, Carmelo Gurnari, Carlos Bravo-Perez, Guillermo Ramil López, Raquel De Paz Arias, Alejandro Sanz, Maria Muñoz Martinez, Francisco Beas, Sandra Novoa Jáuregui, Marta Pratcorona Canela, Silvia Saumell, Maria Teresa Voso, Jaroslaw Maciejewski, Pamela Acha, David Valcarcel, Andres Jerez, Maria Julia Montoro

Blood (2025) 146 (Supplement 1): 4997.

https://doi.org/10.1182/blood-2025-4997

Published: 2025

Journal Articles

Proliferation of mature plasmacytoid dendritic cells in RUNX1-mutated Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 7004.

https://doi.org/10.1182/blood-2025-7004

Published: 2025

Journal Articles

Predicting genetic alterations in Acute Myeloid Leukemia through AI-based analysis of bone marrow morphology

David Bermejo-Peláez, Ana Mendoza Martínez, Miguel Gómez Álvarez, Marta Hidalgo Soto, Nuria Diez, David Brau, Adriana Oños, Sandra Rodríguez, María Postigo, María Linares, María Jesús Ledesma, Maria Julia Montoro, Celina Benavente, Joaquin Martinez Lopez, Miguel Luengo-Oroz

Blood (2025) 146 (Supplement 1): 6124.

https://doi.org/10.1182/blood-2025-6124

Published: 2025

Journal Articles

Beyond TP53: Molecular IPSS-genes multihit status revisited

Blood (2025) 146 (Supplement 1): 2090.

https://doi.org/10.1182/blood-2025-2090

Published: 2025

Journal Articles

Prognostic and therapeutic impact of FLT3 mutations and allelic burden in myelodysplastic syndromes and chronic myelomonocytic leukemia: Results from a multicenter cohort study

Blood (2025) 146 (Supplement 1): 2085.

https://doi.org/10.1182/blood-2025-2085

Published: 2025

Journal Articles

EZH2 molecular alterations drive micromegakaryocyte expansion in MDS defining a specific high-risk group

Blood (2025) 146 (Supplement 1): 2084.

https://doi.org/10.1182/blood-2025-2084

Published: 2025

Journal Articles

Occurrence of immune-mediated inflammatory disorders (IMIDs) during the course of myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) negatively impacts overall survival (OS): A cohort-based study

Jose Torregrosa, Thomas Brunet, Lin-Pierre Zhao, Pierre Fenaux, Arsene Mekinian, Maria Julia Montoro, David Valcarcel, Sophie Dimicoli-Salazar, Estibaliz Lazarro, Claudio Fozza, Yohann Foucher

Blood (2025) 146 (Supplement 1): 2076.

https://doi.org/10.1182/blood-2025-2076

Published: 2025

Journal Articles

Lineage-specific distribution of clonal hematopoiesis of indeterminate potential across mature hematopoietic subpopulations in cancer patients

Blood (2025) 146 (Supplement 1): 4949.

https://doi.org/10.1182/blood-2025-4949

Published: 2025

Journal Articles

Incidence and molecular underpinnings of donor-cell derived neoplasm among spanish transplantation centers

Blood (2025) 146 (Supplement 1): 4275.

https://doi.org/10.1182/blood-2025-4275

Published: 2025

Journal Articles

Newly Developed Prognostic Score for Myelodysplastic Syndrome (MDS) with Isolated 5q Deletion (IPSS-del(5q))

Blood (2024) 144 (Supplement 1): 666.

https://doi.org/10.1182/blood-2024-194405

Published: 2024

Journal Articles

Donor Cell-Derived Hematologic Neoplasms: Role of Germline Predisposition and Clonal Hematopoiesis

Blood (2024) 144 (Supplement 1): 597.

https://doi.org/10.1182/blood-2024-207189

Published: 2024

Journal Articles

The Presence of SH2B3 mutations Identifies a Distinct Subtype of Myelodysplastic Neoplasms

Blood (2024) 144 (Supplement 1): 3214.

https://doi.org/10.1182/blood-2024-194488

Published: 2024

Journal Articles

Evaluating Molecular and Clinical Predictors in Myelodysplastic Syndromes through Machine Learning Integration

Blood (2024) 144 (Supplement 1): 6683.

https://doi.org/10.1182/blood-2024-198114

Published: 2024

Journal Articles

Evaluation of the Prognostic Impact of STAG2 in the Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Francisco Beas, Sandra Novoa Jáuregui, María Gabarrós-Subirà, María Eugenia Rivero, Clàudia Pellín Jou, Pamela Acha, Alba Puyuelo, Silvia Saumell, Ana María Garrido, Félix López Cadenas, Ana Pérez, Carlos Eduardo Chávez, Adoracion Blanco, Laura Gallur, Gloria Hidalgo-Gómez, Francesc Bosch, Maria Julia Montoro, David Valcarcel, Andres Jerez

Blood (2024) 144 (Supplement 1): 6742.

https://doi.org/10.1182/blood-2024-206758

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The presence of SH2B3 mutations identifies a distinct subtype of myelodysplastic neoplasms

Refining the prognostic hierarchy of TP53 multihit alterations and isolated deletion of chromosome 5q in myelodysplastic syndromes

Intermediate and high-risk clonal hematopoiesis in germline predisposition families

Hematologic neoplasms with germline DDX41 variants: Experience from nine spanish centers.

AI-based characterization of terminal erythroid differentiation as a prognostic biomarker in myelodysplastic syndromes

Performance and clinical utility of germline genetic testing criteria for predisposition to myeloid neoplasms in adults

Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy

Proliferation of mature plasmacytoid dendritic cells in RUNX1-mutated Acute Myeloid Leukemia

Predicting genetic alterations in Acute Myeloid Leukemia through AI-based analysis of bone marrow morphology

Beyond TP53: Molecular IPSS-genes multihit status revisited

Prognostic and therapeutic impact of FLT3 mutations and allelic burden in myelodysplastic syndromes and chronic myelomonocytic leukemia: Results from a multicenter cohort study

EZH2 molecular alterations drive micromegakaryocyte expansion in MDS defining a specific high-risk group

Occurrence of immune-mediated inflammatory disorders (IMIDs) during the course of myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) negatively impacts overall survival (OS): A cohort-based study

Lineage-specific distribution of clonal hematopoiesis of indeterminate potential across mature hematopoietic subpopulations in cancer patients

Incidence and molecular underpinnings of donor-cell derived neoplasm among spanish transplantation centers

Newly Developed Prognostic Score for Myelodysplastic Syndrome (MDS) with Isolated 5q Deletion (IPSS-del(5q))

Donor Cell-Derived Hematologic Neoplasms: Role of Germline Predisposition and Clonal Hematopoiesis

The Presence of SH2B3 mutations Identifies a Distinct Subtype of Myelodysplastic Neoplasms

Evaluating Molecular and Clinical Predictors in Myelodysplastic Syndromes through Machine Learning Integration

Evaluation of the Prognostic Impact of STAG2 in the Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only